0001735276-20-000055.txt : 20200422 0001735276-20-000055.hdr.sgml : 20200422 20200422160647 ACCESSION NUMBER: 0001735276-20-000055 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200420 FILED AS OF DATE: 20200422 DATE AS OF CHANGE: 20200422 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vaishnaw Akshay CENTRAL INDEX KEY: 0001458494 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36407 FILM NUMBER: 20808030 MAIL ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001178670 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770602661 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 WEST KENDALL STREET STREET 2: HENRI A. TERMEER SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (617) 551-8200 MAIL ADDRESS: STREET 1: 675 WEST KENDALL STREET STREET 2: HENRI A. TERMEER SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020724 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-04-20 0 0001178670 ALNYLAM PHARMACEUTICALS, INC. ALNY 0001458494 Vaishnaw Akshay 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 0 1 0 0 President, R&D Common Stock 2020-04-20 4 M 0 21000 42.22 A 35119 D Common Stock 2020-04-20 4 M 0 971 42.22 A 36090 D Common Stock 2020-04-20 4 S 0 21971 140.0 D 14119 D Common Stock 515 I by Managed Account Performance Stock Option 2016 (right to buy) 42.22 2020-04-20 4 M 0 21000 0.0 D 2019-08-06 2026-12-20 Common Stock 21000 0 D Stock Option (right to buy) 42.22 2020-04-20 4 M 0 971 0.0 D 2026-12-20 Common Stock 971 5279 D All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 04, 2019. Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Akshay K. Vaishnaw 2020-04-22